Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioStable Science & Engineering develops proprietary cardiovascular medical devices—primarily the HAART family of annuloplasty rings—for surgical repair of the aortic valve. Their products are designed to simplify and standardize complex repairs, offering an alternative to full replacement. The company’s flagship products have received both FDA clearance and CE Mark approval. Over one thousand patients have been treated globally with their technologies. Clinical data show significant improvements in patient outcomes such as reduced need for reoperation and improved survival rates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioStable Science & Engineering.